Silvia Evers (S.M.A.A.)

Li, N., Majoie, M., Evers, S., Rijkers, K., Gubler, F., Rouhl, R., Lazeron, R., Klarenbeek, P., Laskier-Owens, V., & Hiligsmann, M. (2025). Budget impact analysis of cenobamate for epilepsy patients with drug-resistant focal onset seizures in the Netherlands. Journal of Medical Economics, 28(1), 114-123. https://doi.org/10.1080/13696998.2024.2443338

Remmits, A. J. W., van Mastrigt, G. A. P. G., Evers, S. M. A. A., & van Setten, P. A. (2025). Correction to: Facilitators and barriers to the transition from outpatient clinic visits to home-based check-ups for children being treated with growth hormone: a mixed-methods study (vol 183, pg 1857, 2024). European Journal of Pediatrics, 184(3), Article 216. https://doi.org/10.1007/s00431-025-06036-5

Schoonvelde, S. A. C., Wiethoff, I., Zwetsloot, P. P., Hirsch, A., Knackstedt, C., Germans, T., Sikking, M., Schinkel, A. F. L., van Slegtenhorst, M. A., Verhagen, J. M. A., de Boer, R. A., Evers, S. M. A. A., Hiligsmann, M., & Michels, M. (2025). Loss of quality of life and increased societal costs in patients with hypertrophic cardiomyopathy: the AFFECT-HCM study. European heart journal - Quality of care & clinical outcomes, 11(2), 174-185. https://doi.org/10.1093/ehjqcco/qcae092

Majoie, M., Visser, A., Ulubas, M., van Mastrigt, G., Alonso-Coello, P., Valli, C., Niño de Guzman, E., Gartlehner, G., Nussbaumer-Streit, B., Klerings, I., James, R., Service, D., Evers, S., Kleijnen, J., Leone, M., & Verstegen, D. (2025). Curriculum Innovations: Teaching Residents About Guideline Development and Cost-Conscious Care. Neurology ® Education, 4(1), Article 200198. https://doi.org/10.1212/NE9.0000000000200198

Osstyn, S., Rauwenhoff, J., Handels, R., de Vugt, M. E., Evers, S., van Mastrigt, G. A. P. G., & van Heugten, C. M. (2025). Trial-based economic evaluation of the BrainACT study: acceptance and commitment therapy for anxiety and/or depressive symptoms after acquired brain injury. International Journal of Technology Assessment in Health Care, 41(1), Article e10. https://doi.org/10.1017/S0266462324004811

de Mortier, C. A., Yaros, J., van Mastrigt, G. A. P. G., Verstegen, D. M. L., Evers, S. M. A. A., Majoie, M. H. J. M., Dreesens, D. H. H., & Paulus, A. T. G. (2025). Challenges and Stimulating Factors for the Incorporation of Economic Considerations in Clinical Practice Guidelines: A Scoping Review. Journal of Evaluation in Clinical Practice, 31(1), Article e14264. https://doi.org/10.1111/jep.14264

de Mortier, C. A., Klein Haneveld, M. J., Verstegen, D. M. L., van Mastrigt, G. A. P. G., Paulus, A. T. G., Evers, S. M. A. A., Dreesens, D. H. H., & Majoie, M. H. J. M. (2025). Unravelling Education Needs for Clinical Practice Guideline Development: A Survey Performed in the Netherlands. Journal of Evaluation in Clinical Practice, 31(1), Article e14274. https://doi.org/10.1111/jep.14274

Pinckaers, F. M. E., Grutters, J. P. C., Huijberts, I., Gabrio, A., Boogaarts, H. D., Postma, A. A., van Oostenbrugge, R. J., van Zwam, W. H., & Evers, S. M. A. A. (2025). Author's Response to Letter to the Editor Titled "Potential Biases in Post-stroke Health Utility Estimates by Modified Rankin Scale Scores". Value in Health, 28(2), 320-321. https://doi.org/10.1016/j.jval.2024.10.3854

Kleijburg, A., Wijnen, B., den Hollander, W., Evers, S., Kroon, H., Lokkerbol, J., & PHAMOUS Investigators (2025). Mapping of the health of the Nation Outcomes Scale (HoNOS) and Positive and Negative Symptom Scale (PANSS) to the EQ-5D-3L in psychosis patients using the PHAMOUS study. Expert Review of Pharmacoeconomics & Outcomes Research, 25(3), 373-384. https://doi.org/10.1080/14737167.2024.2422456

Daccache, C., Rizk, R., Hiligsmann, M., Evers, S. M. A. A., & Karam, R. (2025). The Lebanese health economic evaluation guideline. Expert Review of Pharmacoeconomics & Outcomes Research, 25(4), 551-565. https://doi.org/10.1080/14737167.2025.2450322